| Authors: |
Soo RA; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore. Electronic address: ross_soo@yahoo.com.au., Fernandez-Penas P; Department of Dermatology, Westmead Hospital and Sydney Medical School, The University of Sydney, Westmead, New South Wales, Australia., Li M; Department of Clinical Oncology, The Chinese University of Hong Kong, N.T., Hong Kong., Voon PJ; Department of Radiotherapy and Oncology, Sarawak General Hospital, Malaysia., Tanizaki J; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan., Tseng JS; Division of Thoracic Oncology, Department of Chest Medicine, Taichung Veterans General Hospital, Taichung, Taiwan; Department of Post-Baccalaureate Medicine, National Chung Hsing University, Taichung, Taiwan., Tan C; Division of Dermatology, Department of Medicine, National University Cancer Institute, Singapore, Singapore., Dong XR; Cancer Center, Huazhong University of Science and Technology, Wuhan, China., Prabhash K; Department of Medical Oncology, Division of Adult Solid Tumor Oncology, Tata Memorial Hospital, Mumbai, India., Kim HR; Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Hasegawa K; NPO Lung Cancer Patients Association One Step, Kanagawa, Japan., Parkinson N; Lung Foundation Australia, Milton, Queensland, Australia., Kam J; Johnson & Johnson, Raritan, NJ, USA., Simoes J; Johnson & Johnson, Raritan, NJ, USA., McGeachie M; Johnson & Johnson, Singapore, Singapore., Lu S; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China., Pavlakis N; Royal North Shore Hospital, The University of Sydney, Sydney, New South Wales, Australia. |
